Literature DB >> 16541305

Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.

Susan E McCann1, Swati Kulkarni, Maurizio Trevisan, Dominica Vito, Jing Nie, Stephen B Edge, Paola Muti, Jo L Freudenheim.   

Abstract

We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16541305     DOI： 10.1007/s10549-006-9196-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


  12 in total

1.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

2.  Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Authors:  Marina S Touillaud; Anne C M Thiébaut; Agnès Fournier; Maryvonne Niravong; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

3.  Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics.

Authors:  Susan E McCann; Katie C Hootman; Anne M Weaver; Lilian U Thompson; Carl Morrison; Helena Hwang; Stephen B Edge; Christine B Ambrosone; Peter J Horvath; Swati A Kulkarni
Journal:  J Nutr       Date:  2011-11-23       Impact factor: 4.798

4.  Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women.

Authors:  Huiru Chang; Song Yao; David Tritchler; Meredith A Hullar; Johanna W Lampe; Lilian U Thompson; Susan E McCann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02       Impact factor: 4.254

5.  Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids.

Authors:  Faizeh Alquobaili; Stacy-Ann Miller; Seid Muhie; Agnes Day; Marti Jett; Rasha Hammamieh
Journal:  J Carcinog       Date:  2010-02-04

6.  Dietary patterns and breast cancer risk in women participating in the Black Women's Health Study.

Authors:  Tanya Agurs-Collins; Lynn Rosenberg; Kepher Makambi; Julie R Palmer; Lucile Adams-Campbell
Journal:  Am J Clin Nutr       Date:  2009-07-08       Impact factor: 7.045

7.  Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Susan E McCann; Lilian U Thompson; Jing Nie; Joan Dorn; Maurizio Trevisan; Peter G Shields; Christine B Ambrosone; Stephen B Edge; Hsin-Fang Li; Christina Kasprzak; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2009-12-22       Impact factor: 4.872

8.  Can rye intake decrease risk of human breast cancer?

Authors:  Herman Adlercreutz
Journal:  Food Nutr Res       Date:  2010-11-10       Impact factor: 3.894

9.  Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.

Authors:  L S Velentzis; M M Cantwell; C Cardwell; M R Keshtgar; A J Leathem; J V Woodside
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

10.  Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women.

Authors:  R Suzuki; T Rylander-Rudqvist; S Saji; L Bergkvist; H Adlercreutz; A Wolk
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.